Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis

被引：0
作者：
Qi Pei
Lu Huang
Jie Huang
Jing-kai Gu
Yun Kuang
Xiao-cong Zuo
Jun-jie Ding
Hong-yi Tan
Cheng-xian Guo
Shi-kun Liu
Guo-ping Yang
机构：
[1] Third Xiangya Hospital,Center of Clinical Pharmacology and Pharmacy Department
[2] Central South University,undefined
[3] Drug Metabolism Research Center of Jilin University,undefined
[4] Children's Hospital of Fudan University,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
schizophrenia; iloperidone; gene polymorphisms; 10; population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1499 / 1508
页数：9
相关论文
共 50 条
[41]   Physiologically based pharmacokinetic modeling to predict the effect of risperidone on aripiprazole pharmacokinetics in subjects with different CYP2D6 genotypes and individuals with hepatic impairment [J].
Mou, Fan ;
Huang, Zhiwei ;
Cheng, Yu ;
Zhao, Xue ;
Sun, Xiujia ;
Li, Huafang ;
Yu, Shunying .
THERAPEUTIC ADVANCES IN DRUG SAFETY, 2024, 15
[42]   Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment [J].
Toja-Camba, Francisco Jose ;
Vidal, Gonzalo Hermelo ;
Vidal-Millares, Maria ;
Duran-Maseda, Maria Jose ;
Rial-Perez, Alicia ;
Maronas, Olalla ;
Carracedo, Angel ;
Gestal, Ana Estany ;
Cajade-Pascual, Francisco ;
Zarra-Ferro, Irene ;
Fernandez-Ferreiro, Anxo ;
Mondelo-Garcia, Cristina .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2024, 135
[43]   Impact of CYP2D6 polymorphisms on efficacy and safety of antipsychotic drugs: a retrospective study about 52 chronic schizophrenic patients [J].
Boulamery, A. ;
Richard, F. ;
Berge-Lefranc, J. L. ;
Richieri, R. M. ;
Lancon, C. ;
Enjalbert, A. ;
Simon, N. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 :21-21
[44]   Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance [J].
Noetzli, Muriel ;
Guidi, Monia ;
Ebbing, Karsten ;
Eyer, Stephan ;
Wilhelm, Laurence ;
Michon, Agnes ;
Thomazic, Valerie ;
Stancu, Ioana ;
Alnawaqil, Abdel-Messieh ;
Bula, Christophe ;
Zumbach, Serge ;
Gaillard, Michel ;
Giannakopoulos, Panteleimon ;
von Gunten, Armin ;
Csajka, Chantal ;
Eap, Chin B. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (01) :135-144
[45]   CYP2D6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapy [J].
Crescenti, Anna ;
Mas, Sergi ;
Gasso, Patricia ;
Parellada, Eduard ;
Bernardo, Miquel ;
Lafuente, Amalia .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (07) :807-811
[46]   Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia [J].
Mihara, K ;
Kondo, T ;
Yasui-Furukori, N ;
Suzuki, A ;
Ishida, M ;
Ono, S ;
Kubota, T ;
Iga, T ;
Takarada, Y ;
de Vries, R ;
Kaneko, S .
THERAPEUTIC DRUG MONITORING, 2003, 25 (03) :287-293
[47]   POPULATION PHARMACOKINETICS OF NORTRIPTYLINE DURING MONOTHERAPY AND DURING CONCOMITANT TREATMENT WITH DRUGS THAT INHIBIT CYP2D6 - AN EVALUATION WITH THE NONPARAMETRIC MAXIMUM-LIKELIHOOD METHOD [J].
JERLING, M ;
MERLE, Y ;
MENTRE, F ;
MALLET, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (05) :453-462
[48]   Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailability [J].
Kerbusch, T ;
Wählby, U ;
Milligan, PA ;
Karlsson, MO .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (06) :639-652
[49]   THE COMBINED EFFECT OF CYP2D6 AND DRD2 Taq1A POLYMORPHISMS ON THE ANTIPSYCHOTICS DAILY DOSES AND HOSPITAL STAY DURATION IN SCHIZOPHRENIA INPATIENTS (OBSERVATIONAL NATURALISTIC STUDY) [J].
Kurylev, Alexey A. ;
Brodyansky, Vadim M. ;
Andreev, Boris V. ;
Kibitov, Alexander O. ;
Limankin, Oleg V. ;
Mosolov, Sergey N. .
PSYCHIATRIA DANUBINA, 2018, 30 (02) :157-163
[50]   The role of CYP2D6 and ABCB1 pharmacogenetics in drug-na⟨ve patients with first-episode schizophrenia treated with risperidone [J].
Jovanovic, Nikolina ;
Bozina, Nada ;
Lovric, Mila ;
Medved, Vesna ;
Jakovljevic, Miro ;
Peles, Alma Mihaljevic .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (11) :1109-1117
12345